share_log

UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $12

Benzinga ·  Oct 30 08:32  · Ratings

UBS analyst Kevin Caliendo maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $9 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment